Search for a trial

A phase Ib/II open-label, multi-center dose escalation study of JDQ443 in
patients with advanced solid tumors harboring the KRAS G12C mutation

This study has been transitioned to CTIS with ID 2023-508073-87-00 check the CTIS register for the current data. Primary objectives:Dose Escalation• To assess the safety and tolerability of JDQ443 single agent and JDQ443 in combination with TNO155,…